Skandinaviska Enskilda Banken (SEB)
AGIO icon

Skandinaviska Enskilda Banken (SEB)’s Agios Pharmaceuticals AGIO Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-32,790
Closed -$1.08M – 837
2024
Q4 		$1.08M Buy
32,790
+3,430
+12% +$161K ﹤0.01% 652
2024
Q3 		$1.3M Hold
29,360
– – 0.01% 646
2024
Q2 		$1.26M Hold
29,360
– – 0.01% 622
2024
Q1 		$858K Sell
29,360
-33,000
-53% -$884K ﹤0.01% 671
2023
Q4 		$1.39M Hold
62,360
– – 0.01% 645
2023
Q3 		$1.54M Buy
62,360
+33,000
+112% +$873K 0.01% 598
2023
Q2 		$834K Hold
29,360
– – 0.01% 726
2023
Q1 		$675K Sell
29,360
-1,403
-5% -$37.3K ﹤0.01% 736
2022
Q4 		$865K Sell
30,763
-1,782
-5% -$50.2K 0.01% 684
2022
Q3 		$920K Hold
32,545
– – 0.01% 697
2022
Q2 		$721K Hold
32,545
– – 0.01% 755
2022
Q1 		$945K Hold
32,545
– – 0.01% 757
2021
Q4 		$1.09M Hold
32,545
– – 0.01% 757
2021
Q3 		$1.5M Hold
32,545
– – 0.01% 717
2021
Q2 		$1.79M Hold
32,545
– – 0.01% 695
2021
Q1 		$1.68M Buy
+32,545
New +$1.61M 0.01% 709

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s AGIO Position: Q1 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Agios Pharmaceuticals (AGIO) in Q1 2025, closing a stake of 32,790 shares — an estimated $1.08M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in AGIO in Q1 2021 and held it in 16 quarters. The position peaked at $1.79M in Q2 2021. 221 funds tracked by Wall St. Rank hold AGIO as of Q1 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Agios Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 32,790 Agios Pharmaceuticals shares in Q1 2025, an estimated $1.08M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Agios Pharmaceuticals in Q1 2021 and held it in 16 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Agios Pharmaceuticals position peaked at $1.79M in Q2 2021.
  • 221 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2025, filed 7 May 2025.